Reply to letter from Li et al.--Atenolol vs nonatenolol β-blockers for the treatment of hypertension: a meta-analysis.
Laura
L
Kuyper
Nadia A
NA
Khan
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage*; D001262:Atenolol / Q000008:administration & dosage* / Q000009:adverse effects*; D002121:Calcium Channel Blockers / Q000008:administration & dosage*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D020521:Stroke / Q000209:etiology*
D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers; D001262:Atenolol